Novartis India MD Sanjay Murdeshwar resignsSanjay Murdeshwar, the Vice Chairman and Managing Director of Novartis India, has resigned from his position. The board of Novartis India h...
Novartis opens new manufacturing plant in Mumbai to make generic cancer drugsSpread across 32,000 sqm, and housing state-of-the-art production technology, the plant is built to cater to export markets. It currently h...
Dr Reddy's inks exclusive sales pact with Novartis IndiaUnder the arrangement, Dr Reddy's will have exclusive rights to promote and distribute the well-established Voveran range, the Calcium rang...
HC directs activist Gokhale to remove tweets against ex-diplomat Lakshmi PuriIn an interim order, Justice C Hari Shankar also restrained Gokhale from posting scandalous tweets against Lakshmi Puri and her husband Uni...
Novartis announces gender-neutral insurance benefit plan for its employeesThe coverage is also extended to children adopted through a legal process by employees, including single and same-sex LGBTI employees, the ...
Novartis announces 26 week gender-neutral parental leaveThe company believes this move will enrich the workplace and foster a more inclusive culture in the organisation.
Novartis picks Sanjay Murdeshwar of AstraZeneca to lead its India businessMurdeshwar according to his current LinkedIn profile is the Global Vice President, Cardio-Renal business at Astrazeneca.
All telcos, except Jio, fail in Trai's call drop test on highway, rail routesAll telcos, except Reliance Jio, failed to meet call drop benchmark in drive test conducted by Trai.
‘Not Hindu’, scientist booted from US garba eventJani, who said he had been doing garba at this venue for the last six years and had never faced any such problem, said he spoke to the orga...
AstraZeneca Pharma India appoints Gagan Singh Bedi as MDThe company has accepted resignation of Sanjay Murdeshwar as MD and as a director. He is shifting to a global role within the AstraZeneca g...
AstraZeneca Q3 net profit at Rs 8.67 croreStandalone total income of the company stood at Rs 144.58 crore for the quarter. It was Rs 108.20 crore for the year ago period.
AstraZeneca rallies over 37% in June on Forxiga launch; more gains likelyAstraZeneca have broken out of the narrow trading range in June, driven by two positive news flows. The stock has rallied 37.41% since June...
AstraZeneca Pharma shares jump on diabetes drug FORXIGA's launchReacting to the development, shares of the company opened on a bullish note at Rs 962.10 and then surged 20 per cent.
Sun Pharma, AstraZeneca seal distribution dealThe drug majors have entered into a distribution services agreement to distribute AstraZeneca's heart disease treatment drug 'Axcer' in Ind...
AstraZeneca, Dr Reddy's ink diabetes drug distribution pactBoth Riax and Riax M are trademarks of the AstraZeneca group. Dr Reddy's Laboratories will be distributing the two drugs in India.
- Upper Bhadra irrigation project case: Yeddyurappa's sons, son-in-law granted anticipatory bail
The Karnataka High Court today granted anticipatory bail to former Chief Minister B S Yeddyurappa's two sons and son-in-law.
- Johnson's Baby launches campaign to aid underprivileged children
Johnson's Baby has launched "Share the Language of Love" campaign in aid of young children from underprivileged backgrounds to provide acce...